ReP USP - Resultado da busca

Artigo de periodico
Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins (2022)
Mottin, Melina; Caesar, Lindsay K.; Brodsky, David; Mesquita, Nathalya Cristina de Moraes Roso; Oliveira, Ketllyn Irene Zagato de; Noske, Gabriela Dias; Sousa, Bruna K. P.; Ramos, Paulo R. P. S.; Jarmer, Hannah; Loh, Bonnie; Zorn, Kimberley M.; Foil, Daniel H.; Torres, Pedro M.; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Scholle, Frank; Ekins, Sean; Cech, Nadja B.; Andrade, Carolina Horta; Laster, Scott M.
Fonte: Bioorganic Chemistry. Unidade: IFSC
Assuntos: ZIKA VÍRUS, PRODUTOS NATURAIS, FLAVIVIRIDAE, ENZIMAS, PROTEÍNAS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTTIN, Melina et al. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins. Bioorganic Chemistry, v. 120, p. 105649-1-105649-12 + supplementary data: 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2022.105649. Acesso em: 30 set. 2024.
APA
Mottin, M., Caesar, L. K., Brodsky, D., Mesquita, N. C. de M. R., Oliveira, K. I. Z. de, Noske, G. D., et al. (2022). Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins. Bioorganic Chemistry, 120, 105649-1-105649-12 + supplementary data: 1-13. doi:10.1016/j.bioorg.2022.105649
NLM
Mottin M, Caesar LK, Brodsky D, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sousa BKP, Ramos PRPS, Jarmer H, Loh B, Zorn KM, Foil DH, Torres PM, Guido RVC, Oliva G, Scholle F, Ekins S, Cech NB, Andrade CH, Laster SM. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins [Internet]. Bioorganic Chemistry. 2022 ; 120 105649-1-105649-12 + supplementary data: 1-13.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105649
Vancouver
Mottin M, Caesar LK, Brodsky D, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sousa BKP, Ramos PRPS, Jarmer H, Loh B, Zorn KM, Foil DH, Torres PM, Guido RVC, Oliva G, Scholle F, Ekins S, Cech NB, Andrade CH, Laster SM. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins [Internet]. Bioorganic Chemistry. 2022 ; 120 105649-1-105649-12 + supplementary data: 1-13.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105649
Artigo de periodico
Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika (2022)
Mottin, Melina ; Sousa, Bruna Katiele de Paula ; Mesquita, Nathalya Cristina de Moraes Roso; Oliveira, Ketllyn Irene Zagato de; Noske, Gabriela Dias; Sartori, Geraldo Rodrigues ; Albuquerque, Aline de Oliveira; Urbina, Fabio; Puhl, Ana C. ; Moreira Filho, José Teófilo; Souza, Guilherme Eduardo de ; Guido, Rafael Victorio Carvalho ; Muratov, Eugene ; Neves, Bruno Junior ; Silva, João Hermínio Martins da ; Clark, Alex E.; Siqueira Neto, Jair L. ; Perryman, Alexander L.; Oliva, Glaucius ; Ekins, Sean ; Andrade, Carolina Horta
Fonte: Journal of Chemical Information and Modeling. Unidade: IFSC
Assuntos: ZIKA VÍRUS, PLANEJAMENTO DE FÁRMACOS, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTTIN, Melina et al. Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika. Journal of Chemical Information and Modeling, v. 62, n. 24, p. 6825-6843, 2022Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.2c00596. Acesso em: 30 set. 2024.
APA
Mottin, M., Sousa, B. K. de P., Mesquita, N. C. de M. R., Oliveira, K. I. Z. de, Noske, G. D., Sartori, G. R., et al. (2022). Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika. Journal of Chemical Information and Modeling, 62( 24), 6825-6843. doi:10.1021/acs.jcim.2c00596
NLM
Mottin M, Sousa BK de P, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sartori GR, Albuquerque A de O, Urbina F, Puhl AC, Moreira Filho JT, Souza GE de, Guido RVC, Muratov E, Neves BJ, Silva JHM da, Clark AE, Siqueira Neto JL, Perryman AL, Oliva G, Ekins S, Andrade CH. Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika [Internet]. Journal of Chemical Information and Modeling. 2022 ; 62( 24): 6825-6843.[citado 2024 set. 30 ] Available from: https://doi.org/10.1021/acs.jcim.2c00596
Vancouver
Mottin M, Sousa BK de P, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sartori GR, Albuquerque A de O, Urbina F, Puhl AC, Moreira Filho JT, Souza GE de, Guido RVC, Muratov E, Neves BJ, Silva JHM da, Clark AE, Siqueira Neto JL, Perryman AL, Oliva G, Ekins S, Andrade CH. Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika [Internet]. Journal of Chemical Information and Modeling. 2022 ; 62( 24): 6825-6843.[citado 2024 set. 30 ] Available from: https://doi.org/10.1021/acs.jcim.2c00596
Artigo de periodico
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 (2022)
Vries, Laura E. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho
Fonte: Nature Communications. Unidade: IFSC
Assuntos: PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, ANTIPARASITÁRIOS, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VRIES, Laura E. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, v. 13, p. 2158-1-2158-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-29688-5. Acesso em: 30 set. 2024.
APA
Vries, L. E., Aguiar, A. C. C., & Guido, R. V. C. (2022). Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, 13, 2158-1-2158-16. doi:10.1038/s41467-022-29688-5
NLM
Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2024 set. 30 ] Available from: https://doi.org/10.1038/s41467-022-29688-5
Vancouver
Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2024 set. 30 ] Available from: https://doi.org/10.1038/s41467-022-29688-5
Artigo de periodico
Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome (2021)
Xie, Stanley C. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho
Fonte: Proceedings of the National Academy of Sciences of the United States of America - PNAS. Unidade: IFSC
Assuntos: PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, MALÁRIA, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIE, Stanley C. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences of the United States of America - PNAS, v. 118, n. 39, p. e2107213118-1-e2107213118-9, 2021Tradução . . Disponível em: https://doi.org/10.1073/pnas.2107213118. Acesso em: 30 set. 2024.
APA
Xie, S. C., Aguiar, A. C. C., & Guido, R. V. C. (2021). Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 118( 39), e2107213118-1-e2107213118-9. doi:10.1073/pnas.2107213118
NLM
Xie SC, Aguiar ACC, Guido RVC. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2021 ; 118( 39): e2107213118-1-e2107213118-9.[citado 2024 set. 30 ] Available from: https://doi.org/10.1073/pnas.2107213118
Vancouver
Xie SC, Aguiar ACC, Guido RVC. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2021 ; 118( 39): e2107213118-1-e2107213118-9.[citado 2024 set. 30 ] Available from: https://doi.org/10.1073/pnas.2107213118

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Grupo de pesquisa

Agência de fomento

Afiliação dos autores externos não normalizada